| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1336 |
| Trial ID | NCT00995137 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD19 CAR-NK cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia |
| Year | 2009 |
| Country | United States |
| Company sponsor | St. Jude Children's Research Hospital |
| Other ID(s) | NKCD19|R01CA113482 |
| Cohort 1 | |||||||||
|
|||||||||